Description
Cipvir 200 Tablet is an antiviral medicine manufactured by Cipla Ltd, containing Favipiravir (200mg) as its active ingredient. Favipiravir is a broad-spectrum antiviral agent that is used in the management of mild to moderate COVID-19 infections and other viral illnesses caused by RNA viruses.
How it Works:
Favipiravir belongs to a class of drugs called RNA polymerase inhibitors. It works by blocking the activity of the viral enzyme RNA-dependent RNA polymerase (RdRp), which is essential for viral replication. By interfering with this process, Cipvir 200 helps to reduce the viral load in the body, control infection spread, and improve recovery in patients.
Uses of Cipvir 200:
-
Treatment of mild to moderate COVID-19 infections
-
May be used in some cases for other influenza-like viral infections (as directed by health authorities/doctor)
Key Benefits:
-
Reduces viral multiplication and controls infection spread
-
Helps in faster recovery from viral symptoms such as fever, cough, and breathing difficulty
-
Decreases viral load in the body and supports the immune system in fighting infection
Dosage & Administration:
-
The dosage is usually higher on the first day (loading dose), followed by a lower dose for the next several days, as prescribed by the doctor.
-
Should be taken orally after meals with water.
-
Dosage and duration depend on age, weight, severity of infection, and medical condition.
Safety & Precautions:
-
To be taken only under medical supervision.
-
Not recommended in pregnant and breastfeeding women due to possible risks.
-
Patients with liver or kidney problems should use it cautiously.
-
Common side effects may include nausea, diarrhea, elevated uric acid, or liver enzyme changes.
-
Regular monitoring of liver function and uric acid levels may be required during treatment.
Leave a Reply